Back

Pathways and biomarkers of selenium deficiency in heart failure patients

17 May 2025 (08:00 - 12:45)
Organised by: Logo
Congress Presentation Part of: From genetic signatures to clinical implications Biomarkers HFA Premium Access Heart Failure 2025 Heart Failure Association (HFA)

About the speaker

Photo
Doctor John Molvin

Department of Cardiology, Malmoe (Sweden)

6 More presentations in this session

Presentation thumbnail
Pathophysiological pathways related to elevated soluble ST2 concentrations and survival in patients with heart failure
Mr T. Bergwerff (Groningen, NL)
Abstract Slides Video
Presentation thumbnail
Genetic architecture and proteomic landscape of acceleration and deceleration capacity as surrogates of cardiac sympathetic and parasympathetic function in heart failure
Ms S. Zeid (Mainz, DE)
Abstract Slides Video
Presentation thumbnail
Circulating mitochondrial DNA signature across the heart failure spectrum
Doctor N. Pugliese (Pisa, IT)
Abstract Slides Video
Presentation thumbnail
Longitudinal assessment of spot urinary sodium as predictor of clinical outcomes in chronic heart failure
Doctor M. Lorenzo Hernandez (Valencia, ES)
Abstract Slides Video
Presentation thumbnail
Peripheral blood cytokine levels do not correlate with myocardial presence of inflammatory cells or MACE in cardiac transthyretin and immunoglobulin light chain amyloidosis
Mr N. Musigk (Berlin, DE)
Abstract Slides Video

Access the full session

Session thumbnail
From genetic signatures to clinical implications
Video

The Event

Event poster

Heart Failure 2025

17 May - 20 May 2025
You may be interested in
thumbnail
Congress Presentation
Selenium, selenoprotein P and autoantibodies to selenium transport proteins in Swedish heart failure patients - a pilot study in preparation for a randomized supplementation trial
thumbnail
Congress Presentation
Biomarker and transcriptomics profiles of serum selenium concentrations in patients with heart failure are associated with immunoregulatory processes
thumbnail
Congress Presentation
Selenium supplementation in heart failure: design and rationale of the SIRI-HF Trial

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources